Marksans Pharma Ltd Annually Results

Gross Sales

2,177.41

1,852.14

1,490.84

1,376.18

1,134.21

Excise Duty

0

0

0

0

0

Net Sales

2,177.41

1,852.14

1,490.84

1,376.18

1,134.21

Other Operating Income

0

0

0

0

0

Other Income

50.42

59.31

41.85

6.69

0.33

Total Income

2,227.83

1,911.45

1,532.69

1,382.88

1,134.54

Total Expenditure

1,718.83

1,512.82

1,231.96

1,036.58

941.96

PBIDT

509

398.63

300.73

346.3

192.58

Interest

11.2

9.13

8.45

7.99

8.75

PBDT

497.8

389.51

292.29

338.32

183.84

Depreciation

74.27

51.85

44.78

36.15

26.66

Minority Interest Before NP

0

0

0

0

0

Tax

113.74

71.23

57.11

66.69

31.95

Deferred Tax

-5.11

1.1

3.59

-3.07

4.47

Reported Profit After Tax

314.9

265.32

186.81

238.54

120.75

Minority Interest After NP

1.2

-0.99

2.25

0

0

Net Profit after Minority Interest

313.7

266.31

184.57

238.54

120.75

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

313.7

266.31

184.57

238.54

120.75

EPS (Unit Curr.)

6.92

6.41

4.51

5.76

2.86

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

60

50

25

25

10

Equity

45.32

45.32

40.93

40.93

40.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

23.37

21.52

20.17

25.16

16.97

PBDTM(%)

22.86

21.03

19.6

24.58

16.2

PATM(%)

14.46

14.32

12.53

17.33

10.64